A survey of patient and caregiver experience with malignant pleural mesothelioma

被引:27
|
作者
Warby, Anne [1 ,2 ]
Dhillon, Haryana M. [1 ]
Kao, Steven [2 ,3 ,4 ]
Vardy, Janette L. [1 ,2 ,4 ,5 ]
机构
[1] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW 2006, Australia
[2] Bernie Banton Ctr, Asbestos Dis Res Inst, Gate 3,Hosp Rd, Concord, NSW 2139, Australia
[3] Chris OBrien Lifehouse, 119-143 Missenden Rd, Camperdown, NSW 2050, Australia
[4] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[5] Concord Repatriat Gen Hosp, Concord Canc Ctr, Hosp Rd, Concord, NSW 2139, Australia
关键词
Malignant pleural mesothelioma; Patient experience; Caregivers; Decision-making; Chemotherapy; PALLIATIVE CARE; DECISION REGRET; EUROPEAN-ORGANIZATION; FAMILY CAREGIVERS; PHASE-III; CHEMOTHERAPY; CISPLATIN; ANXIETY; RISK;
D O I
10.1007/s00520-019-04760-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Malignant pleural mesothelioma (MPM) is a rare cancer with poor prognosis. As there is little information on the lived experience of MPM, our aim was to document the experience of MPM patients and their caregivers. Methods Surveys for MPM patients and caregivers were developed from previous interviews with patients, caregivers, and health professionals, about treatments and decision-making. Participants were recruited from two hospitals, government compensation body, and support groups. Results Survey responses were received from 78 MPM patients and 106 caregivers from January to September 2014. Patients: 85% male, median age 69 years, median time since diagnosis 15 months. Caregivers: median age 68, 91% female, 90% spouse of MPM patient, 95% bereaved. Most participants felt informed about treatment options but only 69% thought all treatment options were discussed. Chemotherapy was discussed most frequently (92-95%); similar to 80% had sufficient information for decision-making. Decision regarding chemotherapy was made by patient considering doctor's opinion (24%), doctor and patient equally (18%), and doctor (17%). Participants 'agreed'/'strongly agreed' that they made the right decision about chemotherapy (patients 81%, caregivers 60%), but 5% and 16%, respectively, regretted the decision. Most participants received 'sufficient' support (71%). A quarter reported seeing cancer nurse specialists. Palliative care referral: 31% patients, 85% caregivers. Caregivers would have liked to talk to someone by themselves (41%), more time with doctors (30%), psychological support (29%), and clearer information (31%). Bereaved caregivers requested grief counselling (39%) and post-death consultation with specialists (23-25%). Conclusions Satisfaction with treatment was high, but participants identified need for improved communication and quality information, discussion about all treatments, end-of-life assistance, and caregiver support after the patient's death.
引用
收藏
页码:4675 / 4686
页数:12
相关论文
共 50 条
  • [41] Malignant pleural mesothelioma
    Ploenes, T.
    Osei-Agyemang, T.
    Nestle, U.
    Waller, C. F.
    Passlick, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (10) : 481 - 486
  • [42] Malignant pleural effusions: the patient experience
    Jones, Rachel
    Steer, Henry
    Preston, Nancy
    Perkins, Paul
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (E2) : E254 - E255
  • [43] Malignant pleural mesothelioma in 2008. Is there really a future for malignant pleural mesothelioma?
    Doddoli, C.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 : 41 - 43
  • [44] Malignant pleural mesothelioma (MPM) in elderly patients: A multicenter survey
    Grosso, Federica
    Botta, Mario
    Zucali, Paolo Andrea
    Pasello, Giulia
    La Spina, Chiara Maria
    Roveta, Annalisa
    Perrino, Matteo
    Beretta, Giordano D.
    Polo, Valentina
    Santoro, Armando
    Favaretto, Adolfo G.
    Ceresoli, Giovanni Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Hemithoracic helical tomotherapy for malignant pleural mesothelioma: Early experience
    Di Muzio, N.
    Cattaneo, G. M.
    Fodor, A.
    Fiorino, C.
    Dell'Oca, I.
    Broggi, S.
    Calandrino, R.
    Fazio, F.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S265 - S266
  • [46] MALIGNANT PLEURAL MESOTHELIOMA: ACCUMULATED EXPERIENCE IN A BRAZILIAN TERTIARY HOSPITAL
    Bibas, Benoit J.
    Terra, Ricardo M.
    Tamagno, Mauro F. L.
    Beyruti, Ricardo
    Pego-Fernandes, Paulo M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1319 - S1319
  • [47] Three Decades of Malignant Pleural Mesothelioma: An Academic Center Experience
    Nasser, Abdullah
    Baird, Andrew
    Saint-Pierre, Mathieu D.
    Amjadi, Kayvan
    Laurie, Scott
    Wheatley-Price, Paul
    CLINICAL LUNG CANCER, 2021, 22 (05) : 441 - 448
  • [48] The Lived Experience of Persons With Malignant Pleural Mesothelioma in the United States
    Walker, Suzanne L.
    Crist, Janice D.
    Shea, Kimberly
    Holland, Sara
    Cacchione, Pamela Z.
    CANCER NURSING, 2021, 44 (02) : E90 - E98
  • [49] Malignant pleural mesothelioma: A single-center experience in Turkey
    Sezer, Ahmet
    Sumbul, Ahmet Taner
    Abali, Huseyin
    Mertsoylu, Huseyin
    Ozyilkan, Ozgur
    MEDICAL SCIENCE MONITOR, 2014, 20 : 825 - 832
  • [50] Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma
    Gibson, Adam E. J.
    Ahmed, Waqas
    Longworth, Louise
    Bennett, Bryan
    Daumont, Melinda
    Darlison, Liz
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2024, 17 (05): : 551 - 563